Trevi Therapeutics, Inc.

Direct answer

Trevi Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TRVI.

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the advancement and commercialization of Haduvio, a potential treatment for debilitating neurologically mediated conditions. This orally administered, extended-release formulation of nalbuphine is currently undergoing Phase IIb/III clinical trials for chronic pruritus (severe itching) and persistent cough experienced by patients with...

Can you invest in Trevi Therapeutics, Inc.?

Yes. Trevi Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TRVI.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Trevi Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.